方法：栓塞实验以肝动脉灌注卡铂注射剂为对照组。
METHODS: carboplatin albumin microsphere was injected to the liver of hybrid dog through hepatic artery, with carboplatin injection as comparison.
目的研究经肝动脉灌注热化疗药治疗肝癌的有效性及安全性。
Objective To investigate the effectiveness and safety of transhepatic arterial infusion of warm chemotherapeutic agents in treating hepatic cancer.
对12例肝癌采用经肝动脉灌注化疗栓塞治疗，观察临床疗效。
Methods 12 patients with liver cancer used TACE then observed clinical efficacy.
目的：观察复方苦参注射液肝动脉灌注治疗中晚期肝癌的临床疗效。
Objective:To observe the clinical therapeutic of Prescription Radix Injection(PRI)hepatic arterial infusion therapy mid-late stage liver cancer.
充分显示出立体 定向适形放疗联合肝动脉灌注对中晚期肝癌的良好效果。
Our present date showed the treatment of HCCs with SDSR plus hepatic artery embolization and infusion has an exact curative effect.
结论：莪术油肝动脉灌注栓塞治疗继发性肝癌是一种有效、低毒的治疗方法。
Conclusion: Oleum Cureumae for hepatic artery perfusion embolism is an effective remedy for SH with low toxicity.
目的：探讨以奥沙利铂为主的肝动脉灌注化疗对结直肠癌多发肝转移患者的治疗效果。
AIM: To evaluate the efficacy of hepatic arterial infusion chemotherapy (HAIC) based on oxaliplatin for treatment of the patients with multiple liver metastases from colorectal cancer.
局部肝动脉门静脉瘘是射频治疗的并发症，常因局部肝动脉灌注不足和门静脉异常灌注，掩盖局部复发征象。
Arteriovenous shunt, as a complication of RFA, can cover local recurrence because of hepatic hypo perfusion and abnormal portal perfusion.
目的探讨经肝动脉灌注32磷玻璃微球（ 32PGMS）核素内照射治疗手术不能切除的肝细胞癌的疗效。
Objective To investigate the efficacy of internal radiation of 32 P glass microspheres( 32 P GMS) in unresected hepatocellular carcinoma(HCC) via subcutaneous arterial port.
通过扫描软件得出肝血流量（BF）、血容量（BV）、对比剂平均通过时间（MTT）、渗透表面积乘积（PS）、肝动脉灌注指数（HAF）。
The liver perfusion parameters including hepatic blood flow(BF), blood volume(BV), mean transit time(MTT), permeability surface area product(PS) and hepatic arterial fraction (HAF)was calculated.
在留取再灌注后的标本时测量肝动脉和门静脉的血流。
Hepatic artery and PV blood flows were measured at post reperfusion collection times.
目的经肝动脉介入性灌注与热灌注化疗治疗中晚期肝癌，观察对比病灶大小、生存期。
Objective To observe and compare the volumes and survival periods of tumors in the patients with advanced liver cancer after treatments of transhepatic arterial infusion and heat infusion.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗，可以改善临床症状、延长存活期。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
结论肝动脉局部灌注化疗对不能手术切除的晚期肝癌，作为治疗手段不失为一种有效的方法。
Conclusions the local infusion chemotherapy via hepatic artery and portal vein was an effective therapy for those who could not undergo the resection of advanced liver cancer.
目的探讨肝动脉、门静脉双重插管区域灌注化疗在中晚期不能切除原发性肝癌应用方法及临床疗效。
Objective To explore the curative effect of double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma.
结论经肝动脉超选择性灌注32 P玻璃微球内照射化疗栓塞治疗肝癌是一种安全有效的方法。
Conclusions Super selective intra-arterial radioembolization with 32 P-glass microspheres is an effective and safe method in treatment of liver cancer.
目的探讨肝动脉化疗栓塞加门静脉持续灌注化疗治疗原发性肝癌的临床价值。
Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.
本文将动脉介入与持续灌注化疗药物两种方法相结合，观察结直肠癌肝转移患者经肝动脉介入栓塞或持续灌注化疗的临床疗效。
This study was designed to evaluate the efficacy of continuous hepatic artery infusion chemotherapy and chemoembolization for the treatment of liver metastases from colorectal cancer.
结果肝肾联合切取过程中，右肾静脉损伤1例，左肾动脉损伤2例，肾灌注不佳3例。
Results: During the procedure of combined liver and kidney harvesting, 1 right renal vein and 2 left renal arteries were injured, 3 renal perfusion were not satisfied.
且门静脉、肝动脉再灌注由血管夹控制。
The portal vein and the hepatic artery reperfusion were controlled by artery clamp.
目的研究肝转移瘤手术切除加肝动脉药盒导管植入系统灌注栓塞的临床疗效。
Objective To study the clinical efficacy of hepatectomy combined with percutaneous port-catheter system (PCS) implantation in the treatment of hepatatic metastatic neoplasms.
动态mr增强动脉期见肝实质灌注异常，门静脉期见异常侧支静脉强化，DCE MRA显示上述改变更直观。
On dynamic enhanced MR scans, abnormal hepatic perfusion during arterial phase and abnormal enhanced collateral veins during portal phase could be seen. The above signs became more obvious on DCE-MRA.
动态增强动脉期7例见肝脏异常灌注，门静脉期肝门区周围异常丰富侧枝血管。
Abnormal perfusion of liver parenchyma in 7 cases could be seen in arterial phase during MR dynamic enhancement. The abnormal collateral branch veins were enhanced during the portal phase.
目的：研究灌注肝动脉和冲洗胆管方式在冷缺血期对大鼠供肝胆管细胞的影响。
Objiective To explore the effect of preservation through hapetic artery and washing biliary tract on biliary tract cell of rats donor liver in cold preservation.
方法对146例进展期胃癌病人分组行腹腔热低渗液灌注及动脉插管化疗，并对其腹腔转移率、肝转移率及3年生存率对照研究。
Methods 146 patients were divided into treated and control group. The peritoneal and hepatic recurrence and 3 year survival rate of each group were analyzed.
实验组在供肝切取冷灌注时及供肝修整完毕后两次应用尿激酶灌洗供肝动脉系统。
We proposed to use urokinase perfusion artery system during graft harvesting and reperfusion at the end of graft trimming in experimental group.
目的研究肝动脉化疗栓塞基础上经皮经肝门静脉灌注化疗治疗晚期肝癌的疗效。
Objective To study the effect of transcatheter chemoembolization(TACE) plus percutaneous transhepatic portochemotherapy(PTP)for the treatment of primary liver cancer(PLC).
目的评价联合应用肝动脉栓塞灌注化疗和部分性脾栓塞治疗肝癌患者脾功能亢进的临床价值。
Objective To study the clinical effect and method of the partial splenic embolization (PSE) in the treatment of hypersplenism.
目的评价联合应用肝动脉栓塞灌注化疗和部分性脾栓塞治疗肝癌患者脾功能亢进的临床价值。
Objective To study the clinical effect and method of the partial splenic embolization (PSE) in the treatment of hypersplenism.
应用推荐